Individualized CAR‑T therapy uses a patient’s own immune system to fight certain types of cancers.

Through a successful patient support program, Novartis is taking diabetes care beyond the pill in India.

The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.

Seeking to evolve the way it educates and engages with healthcare professionals, Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.

Patient community representatives call for improved digital health literacy, standardised digital platforms, and co-creation of digital solutions.

At Novartis, we aim to be a leader in environmental sustainability and a catalyst for positive change both in our own operations and in our supply chain.